May 30, 2017
Dürr Systems AG Employs CETOL 6σ Tolerance Analysis Solution
May 30, 2017
Destination Imagination Global Finals Draws Record 1,470 Student Teams...
May 30, 2017
Trump lashes out at Germany over trade and NATO, promises 'change'
May 30, 2017
Le ton et la tension montent entre Trump et Merkel
May 30, 2017
Kineret® approved in Canada for the treatment of Neonatal-Onset Multisystem Inflammatory Disease (NOMID)
May 30, 2017
Paramount Resources Ltd. Closes the Sale of its Oil and Gas Properties in the Valhalla Area of Alberta for $150 Million
May 30, 2017
Trilogy Energy Corp. Completes Sale of Certain Assets in the Grande Prairie Area of Alberta for $50 Million
May 30, 2017
Resverlogix Receives Approval From Health Canada To Proceed With Fabry Disease Clinical Trial With Lead Compound Apabetalone
May 30, 2017
Canadian Solar Supplies 268 MW Dymond Modules for the DEWA Project in Dubai
May 30, 2017
Pelican Energy Partners Announces Significant Investment in Johnson Specialty Tools
May 30, 2017
ProSciento Appoints Dr. Kelvin Logan, Former Executive at INC Research and Quintiles, to its Board of Directors
May 30, 2017
Arcturus Therapeutics to Receive Up to $3 Million from Cystic Fibrosis Foundation Therapeutics to Advance a Novel LUNAR-Formulated mRNA CFTR Therapeutic
May 30, 2017
Microsemi to Present at Stifel 2017 Technology, Internet & Media Conference
May 30, 2017
BiondVax Announces First Quarter 2017 Financial Results and Update
May 30, 2017
Magewell to Introduce Versatile 12G-SDI 4K Capture Card at InfoComm 2017
May 30, 2017
Can-Fite Reports First Quarter 2017 Financial Results & Provides Clinical Update
May 30, 2017
Independent Advisory Firm Glass Lewis Endorses CypressFirst Nominees McCranie and Martino for Election to Board of Cypress Semiconductor
May 30, 2017
CASI Pharmaceuticals Announces Poster Presentation At ASCO On ENMD-2076 In Patients With Clear Cell Ovarian Carcinoma (CCOC)
May 30, 2017
Janssen Enters Into Worldwide Exclusive License and Collaboration Agreement With Protagonist Therapeutics, Inc. for Oral Interleukin-23 Receptor Antagonist Drug Candidate for the Treatment of Inflammatory Bowel Disease
May 30, 2017
Anatomage Inc. presents latest virtual dissection technology and features at Users Group Meeting 2017

Pages